This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
June quarter revenue rises 136.5%, but Fabtech posts a net loss
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.4 pts more than Nifty Microcap 250 and 9.8 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue for the June 2025 quarter rose 136.5% to Rs 6,800.68 lakh from Rs 2,875.01 lakh, but the company reported a net loss of Rs 612.59 lakh versus Rs 578.60 lakh profit a year earlier. Standalone net loss was Rs 916.04 lakh. Results included a Rs 177.49 lakh exceptional gain from selling 51% of an LLP. The limited review found no material concerns. The company listed on NSE and BSE on October 7, 2025 after an IPO.
Strong sales growth helps, but the net loss and one-off gain may pressure sentiment. Finance costs rose sharply, adding risk to earnings.
| Q2 FY26 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹121.5 Cr | — | — |
| Operating profit | ₹28.08 Cr | — | — |
| Profit after tax | ₹28.11 Cr | — | — |
| EBITDA margin | 25.1% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.